Targovax Investor Event

Agenda:

  • An analyst’s view of the biotech market
    • Geir Hiller Holom, Senior Equity Analyst at DNB Markets
  • Targovax Business Overview
    • Erik Digman Wiklund, CEO of Targovax
  • Circular RNA (circRNA) – the new frontier in RNA therapeutics discovered in Scandinavia
    • Thomas Hansen, VP Research at Targovax

There will be an informal Q&A and serving of food from 17:45.

Lubor Gaal, CFO og Andreas Storsve, VP Business Development, will also be present.

 

Registration by Monday 26 September at 12:00 to renate.birkeli@targovax.com

Oslo Sentralen, Øvre Slottsgate 3 Add to Calendar

Upcoming events

Subscribe

Share